NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
Key Details
Context & Analysis
Food and Drug Administration posted this funding opportunity on July 11, 2025 (opportunity number PAR-25-014). It is catalogued under CFDA number 93.103. Applications are accepted through April 1, 2027 — 253 days remaining.
Similar Grant Opportunities
Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional
Food and Drug Administration
Education and Outreach to Tribal Producers through the Tribal Food Safety Alliance
Food and Drug Administration
Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Food and Drug Administration
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Food and Drug Administration
Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed
Food and Drug Administration
Stay Updated
Get notified about new opportunities matching your interests.